SD Biosensor Inc (KO:137310) — Market Cap & Net Worth
Market Cap & Net Worth: SD Biosensor Inc (137310)
SD Biosensor Inc (KO:137310) has a market capitalization of $499.36 Million (₩736.85 Billion) as of September 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #12306 globally and #347 in its home market, demonstrating a 0.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SD Biosensor Inc's stock price ₩6160.00 by its total outstanding shares 119619215 (119.62 Million). Also see SD Biosensor Inc balance sheet assets for a full breakdown of the balance sheet.
SD Biosensor Inc Market Cap History: 2021 to 2026
SD Biosensor Inc's market capitalization history from 2021 to 2026. Data shows change from $4.45 Billion to $499.36 Million (-35.29% CAGR). Also see 137310 cash generation efficiency for how efficiently the company converts equity into cash flow.
SD Biosensor Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SD Biosensor Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SD Biosensor Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
SD Biosensor Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $4.45 Billion | $2.93 Trillion | $1.06 Trillion | 0.00x | 0.00x |
| 2022 | $2.44 Billion | $2.93 Trillion | $911.36 Billion | 0.00x | 0.00x |
| 2023 | $927.37 Million | $655.68 Billion | -$467.71 Billion | 0.00x | N/A |
| 2024 | $833.34 Million | $694.57 Billion | -$98.41 Billion | 0.00x | N/A |
| 2025 | $721.47 Million | $710.58 Billion | -$512.11 Billion | 0.00x | N/A |
Competitor Companies of 137310 by Market Capitalization
Companies near SD Biosensor Inc in the global market cap rankings as of September 18, 2026. Review tangible equity quality of SD Biosensor Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to SD Biosensor Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
SD Biosensor Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, SD Biosensor Inc's market cap moved from $4.45 Billion to $ 499.36 Million, with a yearly change of -35.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩499.36 Million | -30.79% |
| 2025 | ₩721.47 Million | -13.42% |
| 2024 | ₩833.34 Million | -10.14% |
| 2023 | ₩927.37 Million | -62.06% |
| 2022 | ₩2.44 Billion | -45.11% |
| 2021 | ₩4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of SD Biosensor Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $499.36 Million USD |
| MoneyControl | $499.36 Million USD |
| MarketWatch | $499.36 Million USD |
| marketcap.company | $499.36 Million USD |
| Reuters | $499.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SD Biosensor Inc
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volum… Read more